Oncology Care Model (OCM)

What Is Value-Based Care and What Does It Mean for Providers?

October 07, 2022

What Is Value-Based Care and What Does It Mean for Providers?

What Is Value Based Care?  Value-based care (VBC) is a healthcare model that reimburses providers based on the quality of care provided and the patient outcomes achieved. Put simply, with…

Read more
What Is the Enhancing Oncology Model (EOM)?

August 31, 2022

What Is the Enhancing Oncology Model (EOM)?

The Centers for Medicare and Medicaid Services (CMS) recently announced the Enhancing Oncology Model (EOM), the next iteration of its value-based, oncology care model. EOM is a five year program,…

Read more
Reimagining Value-based Care in Oncology: How the Enhancing Oncology Model will Continue the Evolution of Oncology Care

August 23, 2022

Reimagining Value-based Care in Oncology: How the Enhancing Oncology Model will Continue the Evolution of Oncology Care

by Dr. Jeffrey A. Scott, Chief Medical Officer. In our previous blog post, we broke down CMS’ assessment of the Oncology Care Model (OCM) and found that there were both…

Read more
Reimagining Value-based Care in Oncology: What OCM Can Teach Us Ahead of the Enhancing Oncology Model

August 17, 2022

Reimagining Value-based Care in Oncology: What OCM Can Teach Us Ahead of the Enhancing Oncology Model

by Dr. Charles Saunders, CEO of Integra Connect. The Oncology Care Model (OCM) came to an end in June of 2022, giving oncology providers, payers, and other industry observers the…

Read more
Preparing for the Enhancing Oncology Model: What Practices Need to Do Now

July 14, 2022

Preparing for the Enhancing Oncology Model: What Practices Need to Do Now

The Enhancing Oncology Model (EOM) will begin in July of 2023, giving practices a 12-month runway to prepare for the new value-based care program.  Here’s what prospective participants need to do to…

Read more
rapid genetic testing

June 03, 2022

From ASCO: Early, rapid genetic testing can improve survival rates among late-stage lung cancer patients

Byline: Jeffrey A. Scott, MD, Chief Medical Officer, Integra Connect Advances in genetic testing have made it possible to determine, at a molecular level, which treatment options will best target…

Read more

February 07, 2019

A New Year for Value-Based Oncology Care: Three Things Every Pharma Leader Needs to Know About

For many community oncology practices, 2018 was the year that value-based care became a financial and clinical reality. For example, CMS provided those participating in the Oncology Care Model (OCM)…

Read more

November 28, 2018

OCM Performance Period 2 Results: Practices Still Addressing Performance Gaps and Challenges with CMS Logic

Since this article was originally published, Integra Connect supported OCM-participating oncology providers, practices, and payers for five years and across more than 200,000 patient episodes, representing one of the largest networks…

Read more

November 14, 2018

The 8 Questions EMS Billing Companies are Hoping You Don’t Ask on Your Next RFP

The rising prominence of the Triple Aim has increased pressure on EMS providers to optimize patient satisfaction and reduce healthcare costs – all while still attending to medical emergencies. This…

Read more

April 23, 2018

OCM Practices React to Performance Period 1 Results, Plan to Contest MEOS Recoupment

OCM Performance Period 1 Results Revealed an Unwelcome Surprise In February, practices participating in the Oncology Care Model (OCM) program received their Performance Period 1 (PP1) initial reconciliation reports, which…

Read more